H. pylori infection. Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention 1: Intervention group: First intervention group: furazolidone, proton pump inhibitor, bismuth, amoxicillin. . which is in the form of furazolidone 100 every 12 hours, pentazol 40 every 12
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
17 Years to No maximum
Inclusion criteria
Inclusion criteria: Confirmation of H. pylori infection in patients by standard diagnostic methods Over seventeen years of age
Exclusion criteria
Exclusion criteria: History of known drug sensitivity to the studied drug regimen pregnancy Having chronic diseases (pulmonary, kidney, liver) Unwillingness to participate in the study Patients treated with other treatment methods such as probiotics, other antibiotics, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Eradication and safety of drug regimens containing furazolidone in patients with H. pylori infection. Timepoint: Investigating the eradication rate of H. pylori two weeks after the end of the treatment regimen. Method of measurement: Standard diagnostic methods include RUT, histology staining, bacterial culture, antigen test. | — |
Secondary
| Measure | Time frame |
|---|---|
| H. pylori eradication, drug safety. Timepoint: Two weeks after the end of the eradication treatment. Method of measurement: Urea breath test, fecal antigen, bacterial culture, histology. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSeyed Maryam Moghadam Ziabari
Shahid Beheshti University of Medical Sciences
Outcome results
None listed